Etiqueta: heart failure

Doctors in Houston use autologous adult stem cell therapy to treat heart failure in an FDA-approved clinical trial.

More and more clinical trials are using adult stem cells for the treatment of heart failure, with consistently positive results.

The stem cell company Bioheart has announced FDA authorization to begin Phase I clinical trials for the use of adult stem cells in the treatment of heart failure.

Researchers demonstrate a new way to stimulate endogenous heart stem cells to repair damaged heart tissue.

A number of scientists have expressed concern over new clinical trials in New Zealand which began today, in which cells from newborn pigs are implanted into human volunteers for the treatment of diabetes.

Researchers announce the successful performance of the world’s first cardiac stem cell procedure.

The new Guidelines issued by NIH are seen by many embryonic stem cell scientists as an obstacle to research.

There were approximately 49,000 comments sent into the NIH in response to a publicly available draft of the new guidelines to embryonic stem cell research.

Merger of IZumi Bio and Pierian Inc was announced, with the new company being named IPierian.

Doctors in Los Angeles are testing a method for using the heart’s own stem cells to heal damaged heart tissue.